Reference
Vercelli, Donata. “Microbiota and Human Allergic Diseases: The Company We Keep”. Curr. Opin. Immunol., vol. 72, Oct. 2021, pp. 215–220.
Abstract
Environmental, maternal and early life microbial/immune networks
program human developmental trajectories and health outcomes and
strongly modify allergic disease risk. The effects of
environmental microbiota are illustrated by the 'farm effect'
(the protection against asthma and allergy conferred by growing
up on a traditional farm) and other natural experiments in
populations exposed to microbe-rich environments. The role of
gut microbiome maturation in the asthma/allergy trajectory is
demonstrated by the most recent farm studies, which identified
microbial metabolites specifically associated with asthma
protection, and studies in other cohorts, which defined dynamic
microbial community profiles associated with allergic disease
phenotypes. Current and future studies in germ-free mice
associated with gut microbiota from human disease states are
providing novel mechanistic insights into the role of microbiota
in shaping immune function and allergic disease susceptibility.